Hana Pharm Co., Ltd. (293480.KS)
KRW 11260.0
(0.18%)
KRW 11260.0
(0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 224.45 Billion | 210.84 Billion | 196.4 Billion | 177.3 Billion | 166.34 Billion | 152.83 Billion |
| Cost of Revenue | 83.6 Billion | 79.6 Billion | 65.58 Billion | 63.28 Billion | 56.14 Billion | 50.92 Billion |
| Gross Profit | 140.85 Billion | 131.23 Billion | 130.81 Billion | 114.02 Billion | 110.19 Billion | 101.9 Billion |
| Operating Expenses | 114.72 Billion | 100.06 Billion | 94.8 Billion | 82.34 Billion | 76.63 Billion | 68.34 Billion |
| Selling, General and Administrative Expenses | 55.25 Billion | 48.15 Billion | 41.01 Billion | 26.64 Billion | 25.66 Billion | 24.1 Billion |
| Research and Development Expenses | 7.4 Billion | 4.74 Billion | 3.48 Billion | 3.24 Billion | 2.56 Billion | 2.19 Billion |
| Other Expenses | 49.89 Billion | 47.16 Billion | 50.3 Billion | 52.45 Billion | 48.4 Billion | 30.7 Million |
| Cost and Expenses | 198.32 Billion | 179.67 Billion | 160.39 Billion | 145.63 Billion | 132.78 Billion | 119.26 Billion |
| Operating Income | 27.03 Billion | 31.17 Billion | 36.01 Billion | 31.67 Billion | 33.56 Billion | 33.56 Billion |
| Interest Expense | 600.00 | 585.66 Million | 45.18 Million | 51.99 Million | 55.49 Million | 298.99 Million |
| Income Tax Expense | 5.57 Billion | 6.41 Billion | 7.83 Billion | 13.6 Billion | 6.55 Billion | 6.16 Billion |
| Earnings before Tax | 27.9 Billion | 30.71 Billion | 35.84 Billion | 28.49 Billion | 34.86 Billion | 32.33 Billion |
| Net Income | 22.33 Billion | 24.3 Billion | 28.01 Billion | 14.89 Billion | 28.3 Billion | 26.16 Billion |
| Earnings Per Share Basic | 1291.00 | 1405.08 | 1679.05 | 860.74 | 1616.79 | 1794.94 |
| Earnings Per Share Diluted | 1290.95 | 1405.08 | 1679.05 | 860.74 | 1616.79 | 1794.50 |
| Weighted Average Shares Outstanding | 17.29 Million | 17.29 Million | 16.68 Million | 17.3 Million | 17.5 Million | 14.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 17.29 Million | 17.29 Million | 16.68 Million | 17.3 Million | 17.5 Million | 14.58 Million |
| Gross Margin | 0.63 | 0.62 | 0.67 | 0.64 | 0.66 | 0.67 |
| EBIT Margin | 0.16 | 0.18 | 0.21 | 0.19 | 0.24 | 0.25 |
| Profit Margin | 0.10 | 0.12 | 0.14 | 0.08 | 0.17 | 0.17 |
| EBITDA | 35.48 Billion | 37.73 Billion | 41.65 Billion | 33.54 Billion | 39.11 Billion | 37.5 Billion |
| Earnings Before Tax Margin | 0.12 | 0.15 | 0.18 | 0.18 | 0.20 | 0.22 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 53.49 Billion | 57.06 Billion | 224.45 Billion | 57.37 Billion | 55.6 Billion | 57.36 Billion |
| Cost of Revenue | 18.89 Billion | 21.5 Billion | 83.6 Billion | 21.65 Billion | 21.3 Billion | 21.12 Billion |
| Gross Profit | 34.6 Billion | 35.55 Billion | 140.85 Billion | 35.71 Billion | 34.3 Billion | 36.23 Billion |
| Operating Expenses | 151.57 Billion | 27.92 Billion | 114.72 Billion | 29.85 Billion | -28.78 Billion | -27.59 Billion |
| Selling, General and Administrative Expenses | 26.91 Billion | 25.71 Billion | - | 25.8 Billion | 28.78 Billion | 27.59 Billion |
| Research and Development Expenses | 124.62 Billion | 2.19 Billion | - | 3.55 Billion | 1.85 Billion | 1.64 Billion |
| Other Expenses | -30 Million | -20.59 Million | -721.22 Million | -498.84 Million | -57.56 Billion | -55.18 Billion |
| Cost and Expenses | 170.46 Billion | 49.43 Billion | 198.32 Billion | 51.51 Billion | 21.3 Billion | 21.12 Billion |
| Operating Income | -116.96 Billion | 7.63 Billion | 26.13 Billion | 5.86 Billion | 5.51 Billion | 8.64 Billion |
| Interest Expense | - | 1.03 Billion | 1.03 Billion | 969.38 Million | 240.42 Million | 250.45 Million |
| Income Tax Expense | 637.14 Million | 1.83 Billion | 5.57 Billion | 1.49 Billion | 1.2 Billion | 1.28 Billion |
| Earnings before Tax | 5.66 Billion | 7.9 Billion | 27.9 Billion | 6.98 Billion | 5.03 Billion | 8.99 Billion |
| Net Income | 5.03 Billion | 6.07 Billion | 22.33 Billion | 5.48 Billion | 3.82 Billion | 7.71 Billion |
| Earnings Per Share Basic | 290.84 | 351.17 | - | 317.09 | 221.12 | 445.73 |
| Earnings Per Share Diluted | 290.84 | 351.17 | - | 317.09 | 221.12 | 445.73 |
| Weighted Average Shares Outstanding | 17.29 Million | 17.29 Million | 17.29 Million | 17.29 Million | 17.29 Million | 17.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 17.29 Million | 17.29 Million | 17.29 Million | 17.29 Million | 17.29 Million | 17.29 Million |
| Gross Margin | 0.65 | 0.62 | 0.63 | 0.62 | 0.62 | 0.63 |
| EBIT Margin | -2.15 | 0.17 | - | 0.13 | 0.62 | 0.63 |
| Profit Margin | 0.09 | 0.11 | 0.10 | 0.10 | 0.07 | 0.13 |
| EBITDA | -115.01 Billion | 9.59 Billion | - | 7.73 Billion | 34.3 Billion | 36.23 Billion |
| Earnings Before Tax Margin | -2.19 | 0.13 | 0.12 | 0.10 | 0.10 | 0.15 |
0412
RSSS
ENELCHILE
MMM
603699
5007